Clinical trial
Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast…
NCT00322517 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00322517 |
|---|---|
| Title | Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer |
| Official title | A Phase 2 Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | SU014813 |
| Enrollment | 90 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2009 |
| First posted | May 8, 2006 |
| Last update posted | May 17, 2011 |
| Countries | Germany, Italy, Netherlands, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: